Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosis

Carcinogenesis

Volumn 29, Issue 9, 2008, Pages 1799-1806

  Kotakadi, Venkata S ^a   Jin, Yu ^a   Hofseth, Anne B ^a   Ying, Lei ^a   Cui, Xiangli ^a   Volate, Suresh ^a   Chumanevich, Alexander ^a   Wood, Patricia A ^b   Price, Robert L ^b   Mcneal, Anna ^b   Singh, Udai P ^b   Singh, Narendra P ^b   Nagarkatti, Mitzi ^b   Nagarkatti, Prakash S ^b   Matesic, Lydia E ^a   Auclair, Karine ^c   Wargovich, Michael J ^d   Hofseth, Lorne J ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; GINKGO BILOBA EXTRACT; INDUCIBLE NITRIC OXIDE SYNTHASE; PHOSPHOSERINE; PHOSPHOSERINE 15; PROTEIN P53; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CANCER RISK; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHRONIC INFLAMMATION; COLITIS; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; EFFECTOR CELL; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; COLITIS; CYCLOOXYGENASE 2; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; FORKHEAD TRANSCRIPTION FACTORS; GINKGO BILOBA; IMMUNOENZYME TECHNIQUES; INFLAMMATION; MACROPHAGES; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; PHYTOTHERAPY; PLANT EXTRACTS; T-LYMPHOCYTES, REGULATORY;

EID: 51849157897     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn143     Document Type: Article

References (44)

1. DeFeudis,F.V. et al. (2000) Ginkgo biloba extract (EGb 761) and CNS functions: Basic studies and clinical applications. Curr Drug Targets, 1, 25-58.
2. Maclennan,K.M. et al. (2002) The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog. Neurobiol., 67, 235-257.
3. Itzkowitz,S.H. et al. (2004) Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: The role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol., 287 G7-G17.
4. Hilsden,R.J. et al. (2003) Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: Results from a national survey. Am. J. Gastroenterol., 98, 1563-1568.
5. Head,K. et al. (2004) Inflammatory bowel disease. Part II: Crohn's disease-pathophysiology and conventional and alternative treatment options. Altern. Med. Rev., 9, 360-401.
6. Koltermann,A. et al. (2007) Ginkgo biloba extract EGb 761 increases endothelial nitric oxide production in vitro and in vivo. Cell. Mol. Life Sci., 64, 1715-1722.
7. Ying,L. et al. (2005) Chronic inflammation promotes retinoblastoma protein hyperphosphorylation and E2F1 activation. Cancer Res., 65, 9132-9136.
8. Seril,D.N. et al. (2002) Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig. Dis. Sci., 47, 1266-1278.
9. Reagan-Sbaw,S. et al. (2007) Dose translation from animal to human studies revisited. FASEB J., 17, 17.
10. Tanaka,M. et al. (2007) Apoptotic cell clearance and autoimmune disorder. Curr. Med. Chem., 14, 2892-2897.
11. Park,Y.M. et al. (2006) Preventive effect of Ginkgo biloba extract (GBB) on the lipopolysaccharide-induced expressions of inducible nitric oxide synthase and cyclooxygenase-2 via suppression of nuclear factor-kappaB in RAW 264.7 cells. Biol. Pharm. Bull., 29, 985-990.
12. Rutgeerts,P. et al. (2005) Infliximab for induction and maintenance therapy for ulcerative colitis. N. Engl. J. Med., 353, 2462-2476.
13. Hofseth,L.J. et al. (2003) Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc. Natl Acad. Sci. USA 100, 143-148.
14. Hofseth,L.J. et al. (2006) Identifying and defusing weapons of mass inflammation in carcinogenesis. Biochim Biophys Acta, 1765 74-84.
15. Prasad,K.V. et al. (2003) Apoptosis and autoimmune disorders. Autoimmunity, 36, 323-330.
16. Anderson,G.P. (1996) Resolution of chronic inflammation by therapeutic induction of apoptosis. Trends Pharmacol. Sci., 17, 438-442.
17. Targan,S.R. (2006) Current limitations of IBD treatment: Where do we go from here? Ann. N. Y. Acad. Sci., 1072, 1-8.
18. Kozuch,P.L. et al. (2008) Treatment of inflammatory bowel disease: a review of medical therapy. World J. Gastroenterol., 14, 354-377.
19. Sandberg-Gertzen,H. (1993) An open trial of Cedemin, a Ginkgo biloba extract with PAF-antagonistic effects for ulcerative colitis. Am. J. Gastroenterol., 88, 615-616.
20. Harputluoglu,M.M. et al. (2006) The effects of Ginkgo biloba extract on acetic acid-induced colitis in rats. Turk. J. Gastroenterol., 17, 177-182.
21. Mustafa,A. et al. (2006) Ginkgo biloba attenuates mucosal damage in a rat model of ulcerative colitis. Pharmacol. Res., 53, 324-330.
22. Zhou,Y.H. et al. (2006) Effects of Ginkgo biloba extract on inflammatory mediators (SOD, MDA, TNF-alpha, NF-kappaBp65, IL-6) in TNBS-induced colitis in rats. Mediators Inflamm., 2006, 92642.
23. Zimmermann,M. et al. (2002) Ginkgo biloba extract: From molecular mechanisms to the treatment of Alzhelmer's disease. Cell. Mol. Biol. (Noisy-le-grand), 48, 613-623.
24. Ramalanjaona,G. (2004) Ginkgo biloba for memory enhancement: An update. Altern. Med. Alert, 6, 1-5.
25. Fiscella,M. et al. (1993) Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression. Oncogene, 8, 1519-1528.
26. Sartor,R.B. (2006) Mechanisms of disease: Pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol., 3, 390-407.
27. Neuman,M.G. (2007) Immune dysfunction in inflammatory bowel disease. Transl. Res., 149, 173-186.
28. Corazza,N. et al. (1999) Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(-/-) mice upon transfer of CD4(+)CD45RB(hi) T cells. J. Exp. Med., 190, 1479-1492.
29. Kristensen,N.N. et al. (2006) CXC chemokine receptor 3 expression increases the disease-inducing potential of CD4+ CD25- T cells in adoptive transfer colitis. Inflamm. Bowel Dis., 12, 374-381.
30. Qiu,B.S. et al. (1999) The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis. Nat. Med., 5, 1178-1182.
31. Davidson,N.J. et al. (1996) T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J. Exp. Med., 184, 241-251.
32. Shintani,N. et al. (1998) Involvement of CD4+ T cells in the development of dextran sulfate sodium-induced experimental colitis and suppressive effect of IgG on their action. Gen. Pharmacol., 31 477-481.
33. Kobuchi,H. et al. (1997) Ginkgo biloba extract (EGb 761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7. Biochem. Pharmacol., 53, 897-903.
34. Wadsworth,T.L. et al. (2001) Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced release of nitric oxide. Chem. Biol. Interact., 137, 43-58.
35. Kim,K.S. et al. (2005) Ginkgo biloba extract (EGb 761) induces apoptosis by the activation of caspase-3 in oral cavity cancer cells. Oral Oncol., 41, 383-389.
36. Tian,Y.M. et al. (2003) Effects of Ginkgo biloba extract (EGb 761) on hydroxyl radical-induced thymocyte apoptosis and on age-related thymic atrophy and peripheral immune dysfunctions in mice. Mech. Ageing Dev., 124, 977-983.
37. Liu,K.X. et al. (2007) The effect of Ginkgo biloba extract (EGb 761) pretreatment on intestinal epithelial apoptosis induced by intestinal ischemia/reperfusion in rats: Role of ceramide. Am. J. Chin. Med., 35, 805-819.
38. Ye,C.L. et al. (2007) Effects of EGb 761 on the cell apoptosis induced by H2O2 in RIN-m beta cells. Zhong Yao Cai, 30, 424-428.
39. Lu,G. et al. (2006) Molecular evidence of the neuroprotective effect of Ginkgo biloba (EGb761) using bax/bcl-2 ratio after brain ischemia in senescence-accelerated mice, strain prone-8. Brain Res. 1090, 23-28.
40. Luo,Y. et al. (2002) Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc. Natl Acad. Sci. USA, 99, 12197-12202.
41. Tang,Y.J. et al. (2006) Effects of Ginkgo biloba extract on proliferation and apoptosis of T lymphocytes in vitro in rats with asthma. Zhongguo Zhong Xi Yi Jie He Za Zhi, 26, 47-50.
42. Chao,J.C. et al. (2004) Effects of Ginkgo biloba extract on cell proliferation and cytotoxicity in human hepatocellular carcinoma cells. World J. Gastroenterol., 10, 37-41.
43. Zhou,L.J. et al. (2000) Reactive oxygen species-induced apoptosis in PC12 cells and protective effect of bilobalide. J. Pharmacol. Exp. Ther., 293, 982-988.
44. Kang,X. et al. (2007) Protective effects of Ginkgo biloba extract on paraquat-induced apoptosis of PC12 cells. Toxicol. In Vitro, 21, 1003-1009.